Related Experiment Video
Updated: Oct 3, 2025

12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.2K
Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study
Mst Sharmin Sultana Shimu1, Shafi Mahmud2, Trina Ekwati Tallei3
1Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh.
Molecules (Basel, Switzerland)
|February 15, 2022
Summary
Researchers identified potential Dengue virus inhibitors using computational methods. Promising phytochemicals like Phellodendroside were found to effectively target the Dengue NS2B/NS3 protein, offering new avenues for drug development.
Area of Science:
- Computational chemistry
- Virology
- Drug discovery
Background:
- Dengue virus outbreaks pose a global health crisis with no specific antiviral treatments.
- Existing treatments are limited, necessitating the search for novel therapeutic agents.
Purpose of the Study:
- To identify potent inhibitors of Dengue virus infection using in silico virtual screening and molecular dynamics.
- To explore phytochemical compounds as potential antiviral agents against Dengue.
Main Methods:
- Generated a phytochemical library for virtual screening against Dengue's NS2B/NS3 protein target.
- Conducted docking studies and MM-GBSA calculations to evaluate binding affinities.
- Performed molecular dynamics simulations to analyze complex stability and interactions.
Main Results:
- Identified Phellodendroside, quercimeritrin, and quercetin-7-O-rutinoside as top-ranked inhibitors based on binding free energy.
- Observed key interactions of compounds with active site residues (Lys74, Asn152, Gln167) of NS2B/NS3.
- Molecular dynamics simulations confirmed stable docked complexes with favorable pharmacological properties and no predicted toxicity.
Conclusions:
- This computational study successfully identified promising phytochemical inhibitors for Dengue virus.
- The findings provide a foundation for developing new antiviral drugs targeting the NS2B/NS3 protein.
- In silico methods are valuable for accelerating the discovery of novel Dengue therapeutics.

